Immunology
Congress Materials – National Association of Specialty Pharmacy (NASP 2026)
2026 National Association of Specialty Pharmacy | Sep 22-25 | National Harbor, MD
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Guselkumab Pharmacokinetics and Exposure-Response Relationships Are Consistent Following Intravenous Versus Subcutaneous Induction in Participants with Crohn’s Disease
Geert R. D’Haens, Omoniyi J. Adedokun, Tae Eun Yang, Bruce E. Sands, Silvio Danese, Nat A. Terry, Mobolaji Olurinde, Rian Van Rampelbergh, Marion L. Vetter, Tadakazu Hisamatsu, Remo Panaccione
Pharmacokinetics and Exposure-Response Relationships of Guselkumab Intravenous or Subcutaneous Induction in Participants with Ulcerative Colitis
Laurent Peyrin-Biroulet, Zhenhua Xu, Jie Shao, Tadakazu Hisamatsu, Millie Long, Silvio Danese, Matthew Germinaro, Marion L. Vetter, Shadi Yarandi, Thomas Baker, Jessica R Allegretti, David T Rubin
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.